New Study Shows Meaningful Results with Bimiralisib in Mycosis Fungoides Patients using Scarletred®Vision
Topical Bimiralisib, used in patients with the rare cutaneous form of T-cell lymphoma, known as Mycosis fungoides, and healthy patients, showed substantial results regarding cutaneous drug levels.
SCARLETRED Discovery Program (DP): SaaS as our novel flagship service for industry clinical trials
The DP aims to collaborate with pharmaceutical and biotechnology companies by providing access to our customizable software Scarletred®Vision for exploratory or early-stage clinical studies at a more attractive price point.
Monkeypox Outbreak: The Importance of Further Vaccine Research and Manifestations on Various Skin Types
Starting in May 2022, the monkeypox outbreak has raised public health concerns. The small pox vaccine shows to be effective, but availability is limited. Moreover, the clinical image of a rash varies on different skin tones.
How Artificial Intelligence and Telemedicine are Transforming Hybrid and Home-Based Trials
Digitalization and telemedicine have shown significant advancements in the medical industry. Still, clinical research will continue to need high-quality tools to conduct trials efficiently and decrease strain on patients.